These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Fecal blood loss and plasma salicylate study of salicylsalicylic acid and aspirin. Cohen A J Clin Pharmacol; 1979 Apr; 19(4):242-7. PubMed ID: 312297 [TBL] [Abstract][Full Text] [Related]
5. The effects of enteric coating of aspirin tablets on occult gastrointestinal blood loss. Howe GB; Champion GD; Corrigan AB; Hewson J; Haski A; Day RO; Paull PD; Graham GG Aust N Z J Med; 1977 Dec; 7(6):600-4. PubMed ID: 350214 [TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal blood loss from aspirin and sodium salicylate tablets in man. Leonards JR; Levy G Clin Pharmacol Ther; 1973; 14(1):62-6. PubMed ID: 4539495 [No Abstract] [Full Text] [Related]
8. Comparative study of salsalate and aspirin in osteoarthrosis of the hip or knee. Liyanage SP; Tambar PK Curr Med Res Opin; 1978; 5(6):450-3. PubMed ID: 350497 [TBL] [Abstract][Full Text] [Related]
9. Gastroduodenal mucosal damage with salsalate versus aspirin: results of experimental models and endoscopic studies in humans. Scheiman JM; Elta GH Semin Arthritis Rheum; 1990 Oct; 20(2):121-7. PubMed ID: 2123561 [TBL] [Abstract][Full Text] [Related]
10. Relationship of plasma salicylate levels to pain relief with two different salicylates. Hicklin JA Curr Med Res Opin; 1978; 5(7):572-9. PubMed ID: 359253 [TBL] [Abstract][Full Text] [Related]
11. Effects of salsalate (nonacetylated salicylate) and aspirin on serum prostaglandins in humans. Morris HG; Sherman NA; McQuain C; Goldlust MB; Chang SF; Harrison LI Ther Drug Monit; 1985; 7(4):435-8. PubMed ID: 3866409 [TBL] [Abstract][Full Text] [Related]
12. Enteric-coated pelletized aspirin. Gastrointestinal blood loss and bioavailability. Portek I; Graham G; Fleming A Med J Aust; 1981 Jul; 2(1):39-40. PubMed ID: 6974303 [TBL] [Abstract][Full Text] [Related]
13. Comparison of salsalate and aspirin on mucosal injury and gastroduodenal mucosal prostaglandins. Cryer B; Goldschmiedt M; Redfern JS; Feldman M Gastroenterology; 1990 Dec; 99(6):1616-21. PubMed ID: 2227277 [TBL] [Abstract][Full Text] [Related]
14. Failure of intravenous aspirin to increase gastrointestinal blood loss. Cooke AR; Goulston K Br Med J; 1969 Aug; 3(5666):330-2. PubMed ID: 5306445 [TBL] [Abstract][Full Text] [Related]
15. Salicylates in the management of rheumatoid arthritis. Pinals RS Mod Treat; 1971 Nov; 8(4):796-806. PubMed ID: 5316723 [No Abstract] [Full Text] [Related]
16. Comparative effects of aspirin and enteric-coated aspirin on loss of chromium 51-labeled erythrocytes from the gastrointestinal tract. Robbins DC; Schwartz RS; Kutny K; Vallejo G; Horton ES; Cotter JM Clin Ther; 1984; 6(4):461-6. PubMed ID: 6331883 [TBL] [Abstract][Full Text] [Related]
17. Salsalate and salicylate binding to and their displacement of thyroxine from thyroxine-binding globulin, transthyrin, and albumin. Wang R; Nelson JC; Wilcox RB Thyroid; 1999 Apr; 9(4):359-64. PubMed ID: 10319941 [TBL] [Abstract][Full Text] [Related]
18. Plasma acetylsalicylate and salicylate and platelet cyclooxygenase activity following plain and enteric-coated aspirin. Ali M; McDonald JW; Thiessen JJ; Coates PE Stroke; 1980; 11(1):9-13. PubMed ID: 7355437 [TBL] [Abstract][Full Text] [Related]
19. Aspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesis. Hawthorne AB; Mahida YR; Cole AT; Hawkey CJ Br J Clin Pharmacol; 1991 Jul; 32(1):77-83. PubMed ID: 1888645 [TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal blood loss after diflunisal and after aspirin: effect of ethanol. DeSchepper PJ; Tjandramaga TB; De Roo M; Verhaest L; Daurio C; Steelman SL; Tempero KF Clin Pharmacol Ther; 1978 Jun; 23(6):669-76. PubMed ID: 348379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]